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In this issue of Chemistry & Biology, Kinjo et al. (2008) propose that the addition of oligosaccharides to
the core outer membrane glycosphingolipid in Sphingomonas spp. may be an adaptation that allows bac-
teria to evade recognition by Natural Killer T cells, thus suggesting a remarkable process of host/pathogen
coevolution.The outer membrane lipopolysaccharide
(LPS) is one of the most conserved and
characteristic features of Gram-negative
bacteria. This complex glycolipid is a ma-
jor structural component that determines
bacterial surface binding and permeability
characteristics, and enables Gram-nega-
tive bacteria to thrive in many harsh envi-
ronmental conditions. However, when it
comes to bacterial invasion of animals
and plants, there can be a serious dis-
advantage to possessing such surface
glycolipids. The lipid A core of LPS is rec-
ognized by innate immune signaling re-
ceptors, such as toll-like receptor 4 (TLR4)
in humans (Miller et al., 2005), and its
recognition activates a cascade of host
immune functions (Figure 1). This often
spells trouble for Gram-negative bacteria,
which can be effectively contained and
destroyed by the immune system once it
has been alerted to their presence by
recognition of their LPS molecules.
Given the continual coevolution that oc-
curs through the interactions of microbes
with the immune systems of their hosts,
it is not surprising that many pathogenic
Gram-negative bacteria have modified
the structure of their LPS in order to evade
or modify host immune responses (Rebeil
et al., 2004; Ernst et al., 2006; Miller et al.,
2005). Remarkably, one group of unusual
Gram-negative organisms known as
sphingomonads have gone a step further
and actually eliminated LPS from their
membranes, replacing it with a variety of
glycosphingolipids (GSLs). TheGSLs pro-
duced by sphingomonads, which include
bacteria in the genus Sphingomonas as
well as several other related genera, are
structurally similar to ceramides found
commonly in animal and plant cell mem-
branes. Although ceramides are usually642 Chemistry & Biology 15, July 21, 2008 ªknown for their ability to destabilize mem-
branes and increase membrane perme-
ability (Siskind et al., 2002), the GSLs
of Sphingomonas spp. seem to have ac-
quired membrane-forming capabilities
by replacing the usual b-linked uncharged
proximal sugar typically found in ceram-
ides with an a-linked negatively charged
glucuronyl or galacturonyl sugar. The
unique structure of the Sphingomonas
GSLs most likely endows them with an
ability to stabilize the outer membrane of
the sphingomonads in a manner similar
to LPS.
One intriguing possibility to explain this
remarkably unorthodox membrane com-
position in sphingomonads is that the re-
placement of LPS byGSLs in these organ-
ismsmayhavebeendriven by interactions
of these bacteria with the immune sys-
tems of the various plant or animal hosts
they have colonized or invaded. Since
GSLs are not recognized by LPS recep-
tors (such as TLR4 in mammals), this ma-
jor switch inmembranecomposition could
potentially endow Sphingomonas spp.
with an exceptional ability to evade
immune recognition. However, at least
in mammals this appears not to be the
case, as these organisms do not regularly
colonize or invade tissues and have only
rarely been associated with infectious
diseases despite their widespread occur-
rence in the environment (Kilic et al.,
2007). This suggests that in the absence
of LPS, some other component of these
organisms assumes the lead role as a
target for immune recognition, and the
obvious candidate for this would be
the abundant and structurally distinctive
GSLs. Indeed, two previous reports
demonstrated that monosaccharide-con-
taining forms of Sphingomomas GSLs2008 Elsevier Ltd All rights reservedwere targets for immune recognition in
mice and humans (Kinjo et al., 2005;
Mattner et al., 2005). Remarkably, this
recognition was not mediated by TLR4 or
other related germline encoded innate
immune receptors, but instead relied on
an unusual population of lymphocytes
known as Natural Killer T cells (NKT cells)
which recognize lipids and glycolipids
bound to a specialized antigen presenting
protein called CD1d (Figure 1; Bendelac
et al., 2007).
While recognition of several specific
monosaccharide GSL glycolipids by NKT
cells is well established, it is also known
that the GSLs of many Sphingomonas
spp. containmore complex and heteroge-
neous oligosaccharides as well as varia-
tions in their sphingoid base and fatty
acyl components. How these modifica-
tions of the simple monosaccharide
(GSL-1) structure influence immune rec-
ognition is the topic of a new study in this
issue of Chemistry & Biology. To assess
the significance of GSL complexity for im-
mune recognition, Kinjo et al. (2008) syn-
thesized naturally occurring tetrasacchar-
ide-containing GSLs from S. paucimobilis
(GSL-4A) and S. adhaesiva (GSL-4B). One
of these more complex GSLs was found
to be completely unable to stimulate NKT
cell responses, while the other was only
weakly active in this regard and of much
lower potency than GSL-1. Since the
highly stimulatory monoglycosidic GSL-1
structure is contained within the larger
GSL-4A and GSL-4B molecules, the find-
ings suggest that mammalian cells are
unable to efficiently catabolize the more
complex forms to liberate the simpler
and more immunogenic GSL-1 molecule.
This modification of the basic structure
of the major outer membrane glycolipid
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PreviewsFigure 1. Immune Recognition of Bacterial Glycolipids
At the top, the TLRmediated recognition of the lipid Amoiety of LPS is shown schematically. The lipid A structure of E. coli LPS is highly stimulatory to the immune
system through its interaction with toll-like receptors (TLR4 in humans), whereas the modified tetra-acylated form found in Yersinia pestis is an example of a
nonstimulatory lipid A. At the bottom, the CD1d-mediated presentation of GSL-1 to NKT cells is illustrated along with the stimulatory GSL-1 structure and a non-
stimulatory GSL-4B found in Sphingomonas adhaesiva. The carbohydrate components of the glycolipids are in red, and the lipid moieties are in blue. Negatively
charged groups on the membrane proximal carbohydrates are shown in green. The core oligosaccharide and polysaccharide O-antigens of LPS are indicated
schematically. In the case of LPS, it appears that changes in the number and composition of the acyl chains may be the main strategy used by Gram-negative
pathogens to make these glycolipids less stimulatory to the toll-like receptors. In contrast, the GSLs of Sphingomonas spp. may be rendered invisible to the NKT
cell response by the addition of a larger and more complex glycan.in Sphingomonas spp. to reduce immune
recognition is reminiscent of the manner
in which LPS undergoes modification in
some pathogenic Gram-negative bacteria
to limit its recognition by TLR4, again sug-
gesting a process of coevolution between
microbe and host.
In addition to the complexity of the
carbohydrate structures associated with
Sphingomonas GSLs, diversity is also
known to occur commonly in the lipid por-
tion of these molecules with the presence
of unsaturations and cyclopropyl groups.
These alterations in the structure of the
fatty acyl or sphingoid chains of GSLsmight occur mainly to modulate bacterial
membrane structure and permeability,
but it is intriguing to consider that they
may also play a role in modifying NKT
cell responses to these glycolipids. In
the present study by Kinjo et al., a limited
analysis of the effects of cyclopropana-
tion and unsaturation in synthetic GSLs
indicates that these modifications may
not prevent the recognition of these gly-
colipids by NKT cells, and in some cases
may even enhance such recognition.
This suggests the interesting possibility
that such modifications of the lipid struc-
ture may alter the quality rather than theChemistry & Biology 15, July 21, 2008magnitude of the NKT cell response. In
fact, exactly such an effect has been
observed in studies of synthetic a-galac-
tosylceramide ligands of NKT cells, for
which unsaturations or truncations of the
lipid tails can result in a shift in cytokine
production following NKT cell activation
to create a tolerogenic rather than an
inflammatory or microbicidal response
(Yu and Porcelli, 2005). These possibilities
provide fertile ground for future investi-
gations into the extraordinarily varied
and subtle mechanisms employed by
microbial pathogens to evade immune
responses.ª2008 Elsevier Ltd All rights reserved 643
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Aptamers, sometimes termed ‘‘chem
therapeutic application. The groups
tamer-molecular device as a recept
than a corresponding antibody.
Aptamers are in vitro selected nucleic
acids that assume specific and stable
three-dimensional shapes, thereby pro-
viding highly specific, tight binding to tar-
geted ligands. Many aptamer properties
are comparable to those of protein mono-
clonal antibodies, but the nucleic acid
nature of aptamers offers more exciting
advantages (Nimjee et al., 2005), includ-
ing the potential for chemical synthesis,
convenient modification, chemical versa-
tility, stability, and lack of immunogenic-
ity. Therefore, aptamers can be utilized
for a variety of applications ranging from
diagnostics to therapeutics (Pestourie
et al., 2005; Famulok et al., 2007). Re-
cently, bivalent or multivalent aptamer-
based molecules have been engineered
via different methods to serve as diagnos-
tic probes (Fredriksson et al., 2002), deliv-
ery vectors (Chu et al., 2006), antiviral
agents (Darfeuille et al., 2001), and recep-
tor agonists (McNamara et al., 2008).
Aptamers targeting cell surface recep-
tors have been demonstrated tomodulate
immune responses in vivo, hence attract-
ing renewed attention in the field of ap-
tamer development. In particular, multi-
merized versions of aptamers have been
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successfully engineered and these have
enhanced efficacy over monovalent ap-
tamers. This has been attributed to local
cooperative interactions of multimeric
aptamers and their cognate receptors.
One such approach for aptamer multime-
rization has been described by Santulli-
Marotto et al. (2003). These investigators
used four cytotoxic T cell antigen (CTLA)
aptamers annealed to a complementary
DNA scaffold which resulted in enhanced
binding affinity without changing the
functionality of the individual aptamer
units. Similarly, McNamara et al. (2008)
described that multivalent configurations
of the 4-1BB aptamers costimulated
T cell activation in vitro and promoted tu-
mor rejection in vivo (Figure 1A), thus ex-
ploiting the biological role of 4-1BB as
a T cell costimulatory receptor that pro-
longs cell survival. In this study aptamer
dimers were generated by adding short
complementary sequences to the 30-
ends of the aptamers and allowing them
to anneal in pair-wise fashion. However,
the 21 nucleotide linker in this molecular
device limited the molecular distance
and structural flexibility as well as in vitro
transcribed RNA yields.
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In this issue, Sullenger and colleagues
(Dollins et al., 2008) describe multivalent
configurations of the OX40 aptamer
(Figure 1B) which costimulated T cell
activation in vitro and promoted tumor
rejection in vivo. In this study, 20-fluoro
pyrimidine RNA aptamers with nanomolar
binding constants for the OX40 receptor
were isolated using a standard bead-
based SELEX method. Initially, although
capable of binding OX40, the selected
monomeric aptamers were unable to
stimulate OX40 function. This was not
surprising since the crystal structure of
the OX40-OX40 ligand complex revealed
multiple binding sites for its ligand,
whereas an average of one aptamer was
bound to a single receptor.
Considering the features of multiple
ligand binding sites on OX40, these re-
searchers developed a malleable, DNA
oligonucleotide-based molecular scaffold
which was able to bind two copies of the
aptamer. A polyethylene spacer (18 car-
bons in length) was inserted between the
aptamer annealing sites on the scaffold
to provide flexibility (Figure 1B). With this
scaffold, two OX40 aptamers were ar-
ranged in a flexible conformation, spaced
